Home / All Products / Revalor-XH 10 x 10 Implants 200/20 mg
Canada-wide delivery available. Prescription products may require verification before fulfillment.
All Products

Revalor-XH 10 x 10 Implants 200/20 mg

$989.99
Estimated delivery: 2 to 7 business days
Product Attributes

Key product information

Species Cattle
Ailment Supplements & Wellness
Form Implant
Route Subcutaneous
DIN 2469219
Active Ingredient
Active Ingredients: 20 mg trenbolone acetate and 2 mg estradiol
Strength 200/20 mg mg
Pack Size 10 x 10 Implants
Product Details

Important product information

Review product information, ingredients, storage, warnings, and other important details before ordering.

01 Overview

Overview

Read the product description and usage details.

Overview

Revalor®-XH is an extended-release implant containing 200 mg of trenbolone acetate and 20 mg estradiol. Each implant consists of 10 small yellow pellets, four uncoated and six coated with a polymer for delayed and extended release. Each pellet contains: Active Ingredients: 20 mg trenbolone acetate and 2 mg estradiol. Non-Medicinal Ingredients: 4.25 mg cholesterol, 0.5 mg magnesium stearate, 0.25 mg ethylcellulose N200, 1.69 mg poly-(DL-lactide-co-glycolide) 65:35, 0.08 mg colloidal silica anhydrous. For feedlot Heifers.

Product Details

DIN (Drug Identification Number) 02469219
Active Ingredients Active Ingredients: 20 mg trenbolone acetate and 2 mg estradiol
Approved For Cattle
Therapeutic Use Growth stimulant
Form Implant
Route of Administration Subcutaneous
Strength / Concentration 200/20 mg mg
Pack Size 10 x 10 Implants

Safety & Storage

Storage: Ambient

02 Specifications

Specifications

Review available public product specifications and handling details.

Basic Information

Brand Merck
DIN 2469219
Active Ingredient Active Ingredients: 20 mg trenbolone acetate and 2 mg estradiol
Strength 200/20 mg mg
Pack Size 10 x 10 Implants

Important Notice

Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.